Press Release

Formatech Gives Over $300K in Clinical Fills; Recipients Include GeoVax

Back to      Download PDF Version

Posted: Thursday, January 28, 2010

ANDOVER, Mass.--(BUSINESS WIRE)--Formatech continues its pledge to give back and make a difference in the biotechnology and pharmaceutical community with its Fillanthropy Program. Since the program’s inception, Formatech has donated $308K in aseptic liquid fill and finish manufacturing services to companies developing new drug therapies.

Introduced in August 2009, Formatech’s Fillanthropy Program has awarded fills to GeoVax Labs for their HIV/AIDS vaccine, KAI Pharmaceuticals for their secondary hyperparathyroidism treatment and most recently to ViroMed for their vaccine targeting breast cancer. “Each of us either knows someone or has personally been touched by the impact of a chronic disease,” said Indu Isaacs, CEO of Formatech. “We feel it is important to do our part to help new therapies like these reach the patients in need.”

As an established cGMP contract manufacturer with over 16 years of service, Formatech understands its role in helping to fight disease. It is within this spirit that the Fillanthropy Program was created. “At Formatech, we envision a world where all companies with promising new drug therapies have the opportunity to conduct a full clinical development program,” said Jeffrey Bernard, Formatech’s Director of Business Development.

To obtain more information on participating in the Fillanthropy Program, companies are encouraged to contact Jeffrey Bernard, Director of Business Development at Formatech (jbernard@formatech.com).

Contacts
Formatech, Inc.
Jeffrey Bernard, 978-725-9077 Ext. 3164
Director of Business Development
jbernard@formatech.com
www.formatech.com

---